SCOLR Pharma, Inc. Signs Agreement with The Emerson Group to Provide Sales Support for Nutritional & OTC Products

30 August 2010, 5:16 pm

BOTHELL, Wash., Aug. 30 /PRNewswire-FirstCall/ -- SCOLR Pharma, Inc. (NYSE AMEX: DDD) today announced that it has signed an agreement with The Emerson Group to provide sales support for the Company's new line of extended-release nutritional and over-the-counter drug products. The Emerson Group (www.emersongroup.com), headquartered in Wayne, Pa., is a consumer products ...... Read More »

More Topics from "News"

• Seabeck deaf-blind retreat draws worldwide guests
• SonoSite to Present at Stifel Nicolaus 2010 Healthcare Conference
• Mirina Looks for Court Order on Trademark Suit Ahead of Marina Expansion into microRNA Drugs
• Southern California high school football rankings
• Seattle Genetics Achieves Milestone under Antibody-Drug Conjugate Collaboration with Agensys, an Affiliate of Astellas
• EagleView Technologies™ Launches Solar Roofing Report
• MMG Leverages Comparative Rating Solutions to Drive Growth
• M. Soccer. Season Preview: Defenders
• Nautilus Insurance Group Licenses Vertafore PolicyIssuance